Insider · CIK 0001755126
Kathleen Starkoff
Files at GNTX (GENTEX CORP). First filing -, latest -.
In brief
Kathleen Starkoff files SEC Form 4 as director at GNTX (GENTEX CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kathleen Starkoff has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | GNTX GENTEX CORP | AGrant or award Common Stock | +5,626 | $0.00 | $0 | 36,770 | May 22, 2026 |
| May 15, 2025 | GNTX GENTEX CORP | AGrant or award Common Stock | +5,939 | $0.00 | $0 | 31,144 | May 19, 2025 |
Questions about Kathleen Starkoff
Answered from the filings on this page, as of the latest one.
Is Kathleen Starkoff buying or selling?
Kathleen Starkoff has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kathleen Starkoff's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathleen Starkoff has 0.
Where does Kathleen Starkoff file Form 4?
Kathleen Starkoff has filed Form 4 at GNTX (GENTEX CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.